South Community Birth Program
Vancouver, British Columbia, V5V 3C9, Canada
Location status: Recruiting
NCT Number: NCT06930274
The goal of this observational study is to identify a novel biomarker for stillbirth.
Specifically the aim is to predict perinatal hypoxia using quantitative ultrasound from the placenta (QUS-P) between 35 and 37 weeks gestation.
Interested in participating?
Request Info19 year and older
Female
Observational
Vancouver, British Columbia, V5V 3C9, Canada
Location status: Recruiting
Funding: Wellcome Leap, In Utero Program
Primary outcome: Perinatal hypoxia
Background: Perinatal hypoxia is an inadequate supply to or utilization of oxygen by the fetus. It is typically diagnosed at delivery and can lead to serious medical complications, including encephalopathy, and ultimately stillbirth. Fetal hypoxia represents 23% of neonatal deaths worldwide.
Aim: To predict perinatal hypoxia using quantitative ultrasound from the placenta (QUS-P) between 35 weeks gestation and delivery.
Methods: Raw radio frequency data is collected during ultrasounds between 35 and 37 weeks gestation using ClariusTM (handheld ultrasound). All scans take place at BC Women's Hospital. QUS-P parameters are derived from the raw radio frequency data and analyzed using linear regression.
Impact: The ability to identify perinatal hypoxia as early as 35 weeks gestation will allow for additional monitoring as well as efforts to prepare for immediate intervention if necessary (e.g. c-section, resuscitation, neonatal cooling), prevent progression to encephalopathy, and ultimately stillbirth.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 35-37 weeks gestation
Perinatal hypoxia is defined as meeting one or more of the following:
Contact information is provided by the study sponsor or research team.
University of British Columbia
Other
Acronym: STIMULUS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03407729
Brain Diseases, Central Nervous System Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT05018364
Perinatal Hypoxia
Cairo, Egypt
View Trial DetailsNCT04913324
Brain Damage, Chronic, Brain Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT02377817
Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Halifax, Nova Scotia, Canada
View Trial Details